BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31934165)

  • 1. The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.
    López-Romero R; Rodríguez-Esquivel M; Romero-Morelos P; García-Avilés JE; Serafín-Castillo A; Huerta-Padilla VM; Guerra-Araiza C; Mantilla-Morales A; Monrroy-García A; Aguilar-Urbano MA; Martínez-Castillo MA; Jiménez-Tenorio JA; Salcedo M
    Int J Clin Exp Pathol; 2019; 12(9):3208-3221. PubMed ID: 31934165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.
    Velázquez-Hernández N; Reyes-Romero MA; Barragán-Hernández M; Guerrero-Romero F; Rodríguez-Moran M; Aguilar-Durán M; Lazalde Medina B
    Genet Mol Res; 2015 Jun; 14(2):6094-100. PubMed ID: 26125810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression.
    López-Romero R; Garrido-Guerrero E; Rangel-López A; Manuel-Apolinar L; Piña-Sánchez P; Lazos-Ochoa M; Mantilla-Morales A; Bandala C; Salcedo M
    Int J Clin Exp Pathol; 2013; 6(8):1594-602. PubMed ID: 23923078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.
    D'Arcy V; Pore N; Docquier F; Abdullaev ZK; Chernukhin I; Kita GX; Rai S; Smart M; Farrar D; Pack S; Lobanenkov V; Klenova E
    Br J Cancer; 2008 Feb; 98(3):571-9. PubMed ID: 18195709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.
    Leav I; Lau KM; Adams JY; McNeal JE; Taplin ME; Wang J; Singh H; Ho SM
    Am J Pathol; 2001 Jul; 159(1):79-92. PubMed ID: 11438457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
    Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
    Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.
    Shaaban AM; O'Neill PA; Davies MP; Sibson R; West CR; Smith PH; Foster CS
    Am J Surg Pathol; 2003 Dec; 27(12):1502-12. PubMed ID: 14657709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expressions of DNA methyltransferase 1 (DNMT1) and cyclin A1 (CCNA1) in cervical carcinogenesis.
    Cao J; Dong J; Wang Y; Chen Y
    Int J Clin Exp Pathol; 2019; 12(1):40-49. PubMed ID: 31933719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of estrogen receptor alpha and beta in endometrial carcinomas: correlation with ER beta and clinicopathologic findings in 45 cases.
    Utsunomiya H; Suzuki T; Harada N; Ito K; Matsuzaki S; Konno R; Sato S; Yajima A; Sasano H
    Int J Gynecol Pathol; 2000 Oct; 19(4):335-41. PubMed ID: 11109162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.
    Akhtar MS; Akhter N; Talat A; Alharbi RA; Sindi AAA; Klufah F; Alyahyawi HE; Alruwetei A; Ahmad A; Zamzami MA; Deo S; Husain SA; Badi OA; Khan MJ
    Oncotarget; 2023 May; 14():528-541. PubMed ID: 37235839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.
    El-Sharkawy NM; Radwan WM; Essa ES; Kandeel EZ; Abd El-Fattah EK; Kandil SH; Kamel AM
    Cytometry B Clin Cytom; 2017 Sep; 92(5):355-360. PubMed ID: 27219508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
    Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
    Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues.
    Brandenberger AW; Tee MK; Jaffe RB
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1025-8. PubMed ID: 9506768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells.
    Sun Q; Liang Y; Zhang T; Wang K; Yang X
    Biochem Biophys Res Commun; 2017 Jun; 487(3):625-632. PubMed ID: 28435071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.
    Nair HB; Luthra R; Kirma N; Liu YG; Flowers L; Evans D; Tekmal RR
    Cancer Res; 2005 Dec; 65(23):11164-73. PubMed ID: 16322267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.